期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Genes and Nutrition LetPub Score 6.2
50 ratings
Rate
Reputation 7.0 Influence 5.0 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | GENES NUTR | ||||||||||||||||||||
ISSN | 1865-3499 | ||||||||||||||||||||
h-index | 41 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.springer.com/journal/12263 | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/GNNU | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | BioMed Central | ||||||||||||||||||||
主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 2006 | ||||||||||||||||||||
每年文章數 | 13每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 100.00% | ||||||||||||||||||||
OA Related Info | APC: Yes( EUR2790; USD3390; GBP2490; ) APC waiver:Check Notes Other charges: No Keywords: genomics、nutrition、genetic susceptibility、gene-diet interaction、genetics Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1865-3499%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 13 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Genes and Nutrition] 的評論 | 撰寫評論 |
作者: 筑阳运凡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-02-09 08:37:24 評論於 Too slow(0) 讚! | 筑阳运凡 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:24:26 評論於 The discussion section is the core part of a SCI paper, as it can reflect the breadth and depth of the author's research. Therefore, there is no limit to the number of words in this section. Different articles and authors will have different word counts for the discussion section, ranging from a few thousand to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:16:20 評論於 The discussion section is the core part of a scientific research paper, as it can reflect the breadth and depth of the author's research. Therefore, there is no specific word limit for this section. Different papers and authors will have different lengths for the discussion section, ranging from a few thousand words to tens of thousands of words(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:10:06 評論於 Does the lengthy discussion reflect the author's thoughts on the topic? Does the reviewer have a positive impression of the manuscript?(0) 讚! | Oswald Edie |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 11:18:21 評論於 How many words should typically be used in a discussion?(0) 讚! | 上清雨真 |
作者: Catherine Webster 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-10-15 20:23:03 評論於 Received in late March 2021, it took almost seven months. My colleague was exceptionally fast, only three months, I don't know why mine was so slow(0) 讚! | Catherine Webster |
作者: Catherine Webster 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-03-06 16:17:20 評論於 Review speed: 6.0 | Submission acceptance rate: 75.0 Experience sharing: Submitted on August 29, 2020, under review since November 7, 2020. Received a major revision notification on January 7, 2021, and revised on January 19, 2021. As of February 9, 2021, still under review. I have never seen such a slow journal. It has been almost six and a half months(0) 讚! | Catherine Webster |
作者: 阿尔弗雷德阿贝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-26 16:38:19 評論於 Has anyone submitted before? How fast is the review process? What area of research does it focus on? Thank you(0) 讚! | 阿尔弗雷德阿贝 |
作者: 是你的吉欣呀 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-04 18:15:59 評論於 Review Speed: 1.0 Experience Sharing: Although it has not been long since being included in SCI, the IF is rising rapidly, so it's a good time to submit now(0) 讚! | 是你的吉欣呀 |
作者: INOVE 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-09-04 15:59:47 評論於 Although it was not long time to be included in the sci, but IF rose quickly, and now selectd.(0) 讚! | INOVE |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 11:01:38 評論於 We can only hope for next year, after all, as long as the overall is rising, there is no need to worry. Even if it only rises a little bit each year, it will accumulate over time, which is also good(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 23:32:13 評論於 Bullish, if it rises again tomorrow, it is expected to break through 3 points(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us